# MedScale Project Completion Status

```text
STATUS = PRODUCT_DIFFERENTIATION_REBUILD_IN_PROGRESS
MEDSCALE_TRUSTED_V1_IMPLEMENTATION_COMPLETE = TRUE
MEDSCALE_DESKTOP_CLI_PRODUCT_PHASE_COMPLETE = FALSE
MEDSCALE_IMPLEMENTATION_COMPLETE = FALSE
MEDSCALE_RELEASE_READY = FALSE
PRIVATE_DATA_READY = FALSE
MULTI_CLIENT_RELEASE_READY = FALSE
REAL_PHI_AUTHORIZED = FALSE
MESC_RELEASE_BLOCKING = FALSE
KNOWN_REPOSITORY_OWNED_TRUSTED_V1_RESIDUALS = 0
KNOWN_REPOSITORY_OWNED_DESKTOP_CLI_RESIDUALS = 5
NEXT_PROMOTED_SPEC = 068
```

Repository-owned implementation is canonically complete for Trusted V1 and the separately promoted Desktop+CLI product-launch phase. Specs 060–067 are `CLOSED_CANONICAL`. Spec 067 final exact head `9b4eb25995cdbf23ff7a0b6a389be870d6004c38` passed all six required jobs in run `34936519051`, PR #111 merged normally as `92ff377379c857e31d6be9a58612ba08b5e52cfd`, and post-merge main run `34937549663` passed all six required jobs. No repository-owned Desktop+CLI implementation unit remains promoted. Specs 068+ and mobile remain deferred unless freshly promoted.

This implementation closure does not imply distribution/release qualification. `RELEASE_READY=false`, `PRIVATE_DATA_READY=false`, `MULTI_CLIENT_RELEASE_READY=false`, `REAL_PHI_AUTHORIZED=false`, qualified-hardware budget attainment is unproven, production signing/notarization is not granted, final macOS signed-product/App Sandbox enforcement remains external, and WCAG/assistive-technology qualification remains externally unmeasured. Spec 012/MESC remains optional/deferred and non-blocking.

## 2026-09-15 founder product-bar reopening

The founder rejected the prior Desktop visual direction, the invisibility of real model/runtime state, and the absence of an in-product evidence-backed OpenMed comparison. Specs 068–072 are freshly promoted to rebuild product identity, admit a real local model runtime/HF pack path, expose Model Center, expose OpenMed Evidence Center, and requalify the resulting release candidate. Specs 000–067 remain canonically closed as historical implementation evidence; this new sequence raises the product bar rather than rewriting those closures.
